Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia

Mucosal Immunology

Volumn 10, Issue 5, 2017, Pages 1133-1144

  Lanis, J M ^a,b   Alexeev, E E ^a,b   Curtis, V F ^a,b   Kitzenberg, D A ^a,b   Kao, D J ^a,b   Battista, K D ^a,b   Gerich, M E ^a,b   Glover, L E ^a,b   Kominsky, D J ^a,c   Colgan, S P ^a,b  

^a Mucosal Inflammation Program   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10 RECEPTOR; KYNURENINE; TRYPTOPHAN; DEXTRAN SULFATE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; IN VITRO STUDY; INTERFERON INDUCTION; INTESTINE EPITHELIUM; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM; WOUND HEALING ASSAY; ANIMAL; C57BL MOUSE; COLITIS; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; WOUND HEALING;

ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; KYNURENINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TRYPTOPHAN; WOUND HEALING;

EID: 85018820908     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.133     Document Type: Article

References (60)

1. Candela, M. et al. Interaction of probiotic Lactobacillus and Bifidobacter-ium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 125, 286-292 (2008).
2. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220-230 (2012).
3. Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547 (2011).
4. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science (New York, NY) 336, 489-493 (2012).
5. Sonnenburg, J.L. et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science (New York, NY) 307, 1955-1959 (2005).
6. Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
7. Chaudhry, A. et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566-578 (2011).
8. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
9. Pils, M.C. et al. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur. J. Immunol. 40, 443-448 (2010).
10. Engelhardt, K.R. & Grimbacher, B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr. Top. Microbiol. Immunol. 380, 1-18 (2014).
11. Glocker, E.O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009).
12. Loren, V. et al. Interleukin-10 enhances the intestinal epithelial barrier in the presence of corticosteroids through p38 MAPK activity in Caco-2 Monolayers:apossible mechanism for steroid responsivenessinulcerative colitis. PLoS One 10, e0130921 (2015).
13. Kominsky, D.J. et al. IFN-gamma-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J. Immunol. (Baltimore, MD: 1950) 192, 1267-1276 (2014).
14. Mankertz, J. et al. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 113, 2085-2090 (2000).
15. Youakim, A. & Ahdieh, M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 276 (Part 1), G1279-G1288 (1999).
16. Yoshida, R., Imanishi, J., Oku, T., Kishida, T. & Hayaishi, O. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc. Natl Acad. Sci. USA 78, 129-132 (1981).
17. Yasui, H., Takai, K., Yoshida, R. & Hayaishi, O. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxy-genase: its possible occurrence in cancer patients. Proc. Natl Acad. Sci. USA 83, 6622-6626 (1986).
18. Higuchi, K. & Hayaishi, O. Enzymic formation of D-kynurenine from D-tryptophan. Arch. Biochem. Biophys. 120, 397-403 (1967).
19. Munn, D.H., Shafizadeh, E., Attwood, J.T., Bondarev, I., Pashine, A. & Mellor, A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363-1372 (1999).
20. Matteoli, G. et al. Gut CD103 + dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 59, 595-604 (2010).
21. Nguyen, N.T. et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl Acad. Sci. USA 107, 19961-19966 (2010).
22. Pallotta, M.T. et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12, 870-878 (2011).
23. Ciorba, M.A. et al. Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. J. Immunol. (Baltimore, MD: 1950) 184, 3907-3916 (2010).
24. Muzaki, A.R. et al. Intestinal CD103CD11b dendritic cells restrain colitis via IFN-gamma-induced anti-inflammatory response in epithelial cells. Mucosal Immunol. 9, 336-351 (2015).
25. Thaker, A.I. et al. IDO1 metabolites activate beta-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. Gastroenterology 145, 416-425 e411-e414 (2013).
26. Opitz, C.A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197-203 (2011).
27. Bessede, A. et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511, 184-190 (2014).
28. Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M. & Gonzalez, F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140, 173-179 (1996).
29. Gielen, J.E., Goujon, F.M. & Nebert, D.W. Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. J. Biol. Chem. 247, 1125-1137 (1972).
30. Nguyen, L.P. & Bradfield, C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102-116 (2008).
31. Monteleone, I., MacDonald, T.T., Pallone, F. & Monteleone, G. The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis. Curr. Opin. Gastroenterol. 28, 310-313 (2012).
32. Monteleone, I. et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141, e231 (2011).
33. Mascanfroni, I.D. et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 21, 638-646 (2015).
34. Heller, J.J., Qiu, J. & Zhou, L. Nuclear receptors take center stage in Th17 cell-mediated autoimmunity. J. Clin. Invest. 121, 519-521 (2011).
35. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y. & Kishimoto, T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl Acad. Sci. USA 105, 9721-9726 (2008).
36. Colgan, S.P., Campbell, E.L. & Kominsky, D.J. Hypoxia and mucosal inflammation. Ann. Rev. Pathol. 11, 77-100 (2016).
37. Taylor, M.W. & Feng, G.S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5, 2516-2522 (1991).
38. Kominsky, D.J. et al. An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. J. Immunol. (Baltimore, MD: 1950) 186, 6505-6514 (2011).
39. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNFAU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387-398 (1999).
40. Poland, A., Clover, E., Kende, A.S., DeCamp, M. & Giandomenico, C.M. 3,4,3',4'-Tetrachloro azoxybenzene and azobenzene: potent inducers of aryl hydrocarbon hydroxylase. Science (New York, NY) 194, 627-630 (1976).
41. Wincent, E. et al. Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA 109, 4479-4484 (2012).
42. Bacsi, S.G., Reisz-Porszasz, S. & Hankinson, O. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence. Mol. Pharmacol. 47, 432-438 (1995).
43. Ji, T. et al. Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of DSS-induced colitis. Dig. Dis. Sci. 60, 1958-1966 (2015).
44. Kelchtermans, H., Billiau, A. & Matthys, P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 29, 479-486 (2008).
45. Sheikh, S.Z., Matsuoka, K., Kobayashi, T., Li, F., Rubinas, T. & Plevy, S.E. Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J. Immunol. (Baltimore, MD: 1950) 184, 4069-4073 (2010).
46. Carlin, J.M., Ozaki, Y., Byrne, G.I., Brown, R.R. & Borden, E.C. Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 45, 535-541 (1989).
47. MacKenzie, C.R., Langen, R., Takikawa, O. & Daubener, W. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis. Eur. J. Immunol. 29, 3254-3261 (1999).
48. Poland, A.P., Glover, E., Robinson, J.R. &Nebert, D.W. Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodi-benzo-p-dioxin in mice genetically "nonresponsive" to other aromatic hydrocarbons. J. Biol. Chem. 249, 5599-5606 (1974).
49. Xu, C., Li, C.Y.&Kong, A.N. Inductionofphase I,II and III drug metabolism/ transport by xenobiotics. Arch. Pharm. Res. 28, 249-268 (2005).
50. Fernandez-Salguero, P. et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (New York, NY) 268, 722-726 (1995).
51. Esser, C., Rannug, A. & Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30, 447-454 (2009).
52. Esser, C. & Rannug, A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 67, 259-279 (2015).
53. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640 (2011).
54. Gupta, N.K. et al. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm. Bowel Dis 18, 1214-1220 (2012).
55. Albrecht, E. et al. Metabolite profiling reveals new insights into the regulation of serum urate in humans. Metabolomics 10, 141-151 (2014).
56. Walisser, J.A., Glover, E., Pande, K., Liss, A.L. & Bradfield, C.A. Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc Natl Acad Sci USA 102, 17858-17863 (2005).
57. Frick, J.S., MacManus, C.F., Scully, M., Glover, L.E., Eltzschig, H.K. & Colgan, S.P. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 182, 4957-4964 (2009).
58. Tomita, S., Sinal, C.J., Yim, S.H. & Gonzalez, F.J. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha. Mol. Endocrinol. 14, 1674-1681 (2000).
59. Dieleman, L.A. et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114, 385-391 (1998).
60. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).